CYCN Stock Alert: Halper Sadeh Investigates Fairness of Korsana Biosciences Merger

jueves, 2 de abril de 2026, 1:10 am ET1 min de lectura
CYCN--

Halper Sadeh LLC is investigating whether Cyclerion Therapeutics is obtaining a fair price for its shareholders in its merger with Korsana Biosciences. The investigation concerns potential violations of federal securities laws and fiduciary duties, including failing to obtain the best possible price and disclose material information. Halper Sadeh may seek increased consideration, additional disclosures, or other relief and benefits on behalf of shareholders.

CYCN Stock Alert: Halper Sadeh Investigates Fairness of Korsana Biosciences Merger

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios